This event is organized by the Sanofi T1D Medical Team. The webinar will be offered in an English version and a French version, respectively.

 

The webinar is designed to inform healthcare professionals and stakeholders about the autoimmune nature of type 1 diabetes (T1D), highlighting the presymptomatic stages and the crucial importance of early screening and detection strategies. Attendees will obtain valuable information on recent innovations and strategies for the management of T1D.

Join our distinguished speakers as they share their clinical expertise on disease progression and therapeutic interventions, taking into account both physician and patient perspectives.

Learning Objectives:

  • Describe the autoimmune pathophysiology of autoimmune T1D and how disease progression can be quantified.
  • Exploring the clinical importance of screening and how to identify people at increased risk of developing autoimmune T1D.
  • Discuss the clinical management of people with early-stage autoimmune T1D, including emerging treatment options.

Speakers for the Webinar in English:

  • Dr. Bruce Perkins is a Professor of Medicine in the Division of Endocrinology and Metabolism at the University of Toronto.
  • Dr. Constadina Panagiotopoulos is a Pediatric Endocrinologist at the BC Children’s Hospital. She is also a researcher involved in the CanScreen T1D research consortium’s ‘Creation of a Canadian T1D Genetic Data Repository to Validate a Trans-Ethnic Genetic Risk Score (GRS)’ and ‘Establishment of Canadian clinical autoantibody lab’ projects.
  • Dr. Lara Green is the National Manager of Research and Training Programs at JDRF Canada.

Speakers for the Webinar in French:

  • Dr. Rémi Rabasa-Lhoret is a Professor of Medicine and Nutrition at the University of Montreal. He is also a researcher involved in the CanScreen T1D research consortium’s ‘Creation of a Canadian T1D Genetic Data Repository to Validate a Trans-Ethnic Genetic Risk Score (GRS)’ project.
  • Dr. Despoina Manousaki is an Assistant Professor, Departments of Pediatrics and Biochemistry and Molecular Medicine at the University of Montreal. She is also the principal investigator of the CanScreen T1D research consortium’s ‘Creation of a Canadian T1D Genetic Data Repository to Validate a Trans-Ethnic Genetic Risk Score (GRS)’ project.

Event Details:

  • Webinar in English: October 24, 2024, from 7 p.m. to 8 30 p.m. in Eastern Time (US and Canada)
  • Webinar in French: November 1, 2024, from 12 p.m. to 1 p.m. in Eastern Time (US and Canada)
  • Virtual webinars

 

Don’t miss this opportunity to explore cutting-edge approaches and participate in meaningful discussions on advancing the management of T1D. Click here to register for the webinar in English and here to register for the webinar in French.

If you have any questions or require further information, please email aT1D@sanofi.com.